Abstract: Morbihan syndrome is a rare entity that more commonly affects women in the third or fourth decade of life. It is considered a special form of rosacea and its pathogenesis is not fully known. It is clinically characterized by the slow appearance of erythema and solid edemas on the upper portion of the face, with accentuation in the periorbital region, forehead, glabella, nose, and cheeks. We report the case of a patient presented with edema on the upper eyelid for a year. These findings suggested the diagnosis of Morbihan syndrome. We aim to report a rare, particularly refractory and chronic form of rosacea, which has received little attention in the literature.
INTRODUCTION
Morbihan disease was first reported in 1957 by Robert Degos. 1 It is believed that "Morbihan syndrome" is a more correct term in consideration of different etiopathogenic factors.
Morbihan syndrome is a rare entity that mostly affects Caucasian adults of both sexes. Only one black and one Indian male patient were reported. 2, 3 The pathogenesis of the syndrome is not well elucidated. 4 According to most authors, it is a clinical variety of acne or rosacea, a common episodic chronic cutaneous disorder that affects the face. It is characterized by the permanent presence of erythema accompanied by telangiectasia, with frequent mixed facial flushing, papules, pustules, diffuse edema, and nodules. 5, 6 According to some authors, Morbihan syndrome can be caused by abnormalities in lymphatic vessels. 7 Clinically, the syndrome is characterized by the slow appearance of erythema and solid edemas on the upper portion of the face, with accentuation in the periorbital region, forehead, glabella, nose, and cheeks.8 The cutaneous lesions persist indefinitely with no tendency to spontaneous involution without treatment. Lesions are initially floating and then permanent, causing swelling and distortion of facial contours. 8 As the persistent facial edema can lead to visual impairment in severe cases, control of the disease activity is essential.
Laboratory results are nonspecific or not found, histopathology and staining should be performed to rule out other conditions.
Differential diagnoses include orofacial granulomatosis, sarcoidosis, Hansen's disease, systemic lupus erythematosus, cutaneous leishmaniasis, foreign body granuloma, facial granuloma, superior vena cava syndrome, and scleredema of Buschke. 4 Moreover, barbiturates, chlorpromazine, diltiazem, and isotretinoin can induce clinical manifestations similar to Morbihan syndrome.
A number of treatment options are suggested with several systemic drugs used in high doses for a prolonged period. However, not all patients respond to treatment.
The aim of this study was to report a Morbihan disease patient with refractory and chronic rosacea, a rare case that has received little attention in the literature. The patient stated that he had used tetracycline twice a day for 30 days, in addition to soap and sunscreen with no improvement. Dermatological examination revealed erythema and edema on the upper eyelids (Figures 1 and 2) .
A biopsy showed a superficial dermatitis and perifolliculitis, focal granulomatous reaction, ectasia of the cutaneous superficial vascular plexus, and demodicosis corresponding histologically to a picture of rosacea (Figures 3 and 4) .
Considering the hypothesis of Morbihan syndrome, we ordered new tests -including specific stains for mast cells and mucin, X-ray, thoracic CT, and biochemical tests -in order to rule out other diseases ( Figures 5 and 6 ).
9 All exams were within the normal range.
FIgure 1:
E r y t h e m a and edema on the upper eyelids Several systemic drugs have been used including thalidomide, clofazimine, tetracyclines, and steroids.8 However, only isotretinoinalone or associated with ketotifen -has been reported to be effective at a dose ranging from 10-20 mg daily for 3-6 months in combination with ketotifen (1 mg twice daily) with little response though.
